MIMPARA

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Mexico, Netherlands, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug MIMPARA contains one active pharmaceutical ingredient (API):

1 Cinacalcet
UNII 1K860WSG25 - CINACALCET HYDROCHLORIDE

Cinacalcet is a calcimimetic agent which directly lowers PTH levels by increasing the sensitivity of the calcium sensing receptor to extracellular calcium. The reduction in PTH is associated with a concomitant decrease in serum calcium levels.

Read about Cinacalcet

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MIMPARA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H05BX01 Cinacalcet H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05B Anti-parathyroid agents → H05BX Other anti-parathyroid agents
Discover more medicines within H05BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 544115030000017, 544115030000117, 544115030000217
Country: EE Ravimiamet Identifier(s): 1205121, 1205132, 1205143, 1205154, 1205165, 1205176, 1205187, 1205198, 1205200, 1205211, 1205222, 1205233, 1753039, 1753040, 1753051
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 04292002, 04292006, 04292010, 104292013, 104292014, 104292015
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 444217, 453891, 549575
Country: FR Base de données publique des médicaments Identifier(s): 60632346, 60889903, 61326733, 63023578, 63293417, 68434003
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 375973, 375976, 375979, 89555, 89573, 89596
Country: IE Health Products Regulatory Authority Identifier(s): 88409, 88422, 88463, 88724
Country: IT Agenzia del Farmaco Identifier(s): 036598023, 036598050, 036598098
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1029794, 1029795, 1029796, 1029797, 1029798, 1029799, 1029800, 1029801, 1029802, 1029803, 1029804, 1029805, 1050909, 1050912, 1083926, 1083927, 1083928
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 213M2011
Country: NL Z-Index G-Standaard, PRK Identifier(s): 161446, 161454, 161462, 77100, 77119, 77127
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100102921, 100103984, 100104966, 100418050, 100418067, 100418073
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W43185002, W43186002
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699862090100, 8699862090117, 8699862090124

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.